**** SECTION 2 - COMPOSITION, INFORMATION ON INGREDIENTS ****
+----------------+--------------------------------------+----------+-----------+
| CAS# | Chemical Name | % | EINECS# |
|----------------|--------------------------------------|----------|-----------|
| 54-21-7 |SODIUM SALICYLATE | >99.5 | 200-198-0 |
+----------------+--------------------------------------+----------+-----------+
Hazard Symbols: XN
Risk Phrases: 22
**** SECTION 3 - HAZARDS IDENTIFICATION ****
EMERGENCY OVERVIEW
Harmful if swallowed.
Potential Health Effects
Eye:
May cause eye irritation and possible damage.
Skin:
May cause skin irritation. May be harmful if absorbed through the
skin.
Ingestion:
May cause gastrointestinal irritation with nausea, vomiting and
diarrhea. May cause muscle tremor and impaired motor function. May
cause gastric disturbances and electrolytic imbalance. May cause
systemic toxic effects on the heart, liver, and kidneys. May be
harmful if swallowed.
Inhalation:
May cause respiratory tract irritation.
Chronic:
Chronic ingestion may cause effects similar to those of acute
ingestion. May cause reproductive and fetal effects.
**** SECTION 4 - FIRST AID MEASURES ****
Eyes:
Immediately flush eyes with plenty of water for at least 15 minutes,
occasionally lifting the upper and lower eyelids. Get medical aid
immediately.
Skin:
Get medical aid. Immediately flush skin with plenty of water for at
least 15 minutes while removing contaminated clothing and shoes.
Wash clothing before reuse.
Ingestion:
If victim is conscious and alert, give 2-4 cupfuls of milk or water.
Never give anything by mouth to an unconscious person. Get medical
aid immediately.
Inhalation:
Remove from exposure and move to fresh air immediately. If not
breathing, give artificial respiration. If breathing is difficult,
give oxygen. Get medical aid.
Notes to Physician:
Follow with gastric lavage with activated charcoal. If available,
administer ferric hexacyanoferrate as a gastrointestinal trapping
agent. Treat symptomatically and supportively.
**** SECTION 5 - FIRE FIGHTING MEASURES ****
General Information:
As in any fire, wear a self-contained breathing apparatus in
pressure-demand, MSHA/NIOSH (approved or equivalent), and full
protective gear. Dusts at sufficient concentrations can form
explosive mixtures with air. During a fire, irritating and highly
toxic gases may be generated by thermal decomposition or combustion.
Extinguishing Media:
For small fires, use water spray, dry chemical, carbon dioxide or
chemical foam. Use agent most appropriate to extinguish fire. For
large fires, use dry chemical, carbon dioxide, water spray, or
regular foam.
**** SECTION 6 - ACCIDENTAL RELEASE MEASURES ****
General Information: Use proper personal protective equipment as indicated
in Section 8.
Spills/Leaks:
Clean up spills immediately, observing precautions in the Protective
Equipment section. Sweep up, then place into a suitable container for
disposal. Avoid generating dusty conditions. Provide ventilation.
**** SECTION 7 - HANDLING and STORAGE ****
Handling:
Wash thoroughly after handling. Remove contaminated clothing and
wash before reuse. Use with adequate ventilation. Minimize dust
generation and accumulation. Keep container tightly closed. Do not
get on skin or in eyes. Do not ingest or inhale.
Storage:
Store in a cool, dry, well-ventilated area away from incompatible
substances. Keep containers tightly closed.
**** SECTION 8 - EXPOSURE CONTROLS, PERSONAL PROTECTION ****
Engineering Controls:
Facilities storing or utilizing this material should be equipped
with an eyewash facility and a safety shower. Use adequate
ventilation to keep airborne concentrations low.
Exposure Limits
CAS# 54-21-7:
Personal Protective Equipment
Eyes:
Wear appropriate protective eyeglasses or chemical
safety goggles as described by OSHA's eye and face
protection regulations in 29 CFR 1910.133 or European
Standard EN166.
Skin:
Wear appropriate protective gloves to prevent skin
exposure.
Clothing:
Wear appropriate protective clothing to prevent skin
exposure.
Respirators:
Follow the OSHA respirator regulations found in 29
CFR 1910.134 or European Standard EN 149. Use a
NIOSH/MSHA or European Standard EN 149 approved
respirator if exposure limits are exceeded or if
irritation or other symptoms are experienced.
**** SECTION 9 - PHYSICAL AND CHEMICAL PROPERTIES ****
Physical State: Solid
Color: white
Odor: none reported
pH: 5-6
Vapor Pressure: Negligible.
Viscosity: Not available.
Boiling Point: Not available.
Freezing/Melting Point: 200 deg C
Autoignition Temperature: > 250 deg C (> 482.00 deg F)
Flash Point: Not applicable.
Explosion Limits, lower: Not available.
Explosion Limits, upper: Not available.
Decomposition Temperature: Not available.
Solubility in water: Soluble in water.
Specific Gravity/Density: Not available.
Molecular Formula: C7H5NaO3
Molecular Weight: 160.023
**** SECTION 10 - STABILITY AND REACTIVITY ****
Chemical Stability:
Stable under normal temperatures and pressures.
Conditions to Avoid:
High temperatures, incompatible materials, light.
Incompatibilities with Other Materials:
Strong oxidizing agents,strong acids, light.
Hazardous Decomposition Products:
Carbon monoxide, irritating and toxic fumes and gases, carbon
dioxide, sodium oxide.
Hazardous Polymerization: Has not been reported.
**** SECTION 11 - TOXICOLOGICAL INFORMATION ****
RTECS#:
CAS# 54-21-7: VO5075000
LD50/LC50:
CAS# 54-21-7: Oral, mouse: LD50 = 540 mg/kg; Oral, rabbit: LD50 =
1700 mg/kg; Oral, rat: LD50 = 930 mg/kg.
Carcinogenicity:
SODIUM SALICYLATE -
Not listed by ACGIH, IARC, or NTP.
Other:
See actual entry in RTECS for complete information.
**** SECTION 12 - ECOLOGICAL INFORMATION ****
Other
No information available.
**** SECTION 13 - DISPOSAL CONSIDERATIONS ****
Products which are considered hazardous for supply are classified as Special
Waste and the disposal of such chemicals is covered by regulations which may
vary according to location. Contact a specialist disposal company or the local
waste regulator for advice. Empty containers must be decontaminated before
returning for recycling.
**** SECTION 14 - TRANSPORT INFORMATION ****
IATA
Not regulated as a hazardous material.
IMO
Not regulated as a hazardous material.
RID/ADR
Not regulated as a hazardous material.
**** SECTION 15 - REGULATORY INFORMATION ****
European/International Regulations
European Labeling in Accordance with EC Directives
Hazard Symbols: XN
Risk Phrases:
R 22 Harmful if swallowed.
Safety Phrases:
WGK (Water Danger/Protection)
CAS# 54-21-7: 1
Canada
CAS# 54-21-7 is listed on Canada's DSL List.
CAS# 54-21-7 is not listed on Canada's Ingredient Disclosure List.
US FEDERAL
TSCA
CAS# 54-21-7 is listed on the TSCA inventory.
**** SECTION 16 - ADDITIONAL INFORMATION ****
MSDS Creation Date: 4/08/1998 Revision #2 Date: 3/18/2003
The information above is believed to be accurate and represents the best
information currently available to us. However, we make no warranty of
merchantability or any other warranty, express or implied, with respect to
such information, and we assume no liability resulting from its use. Users
should make their own investigations to determine the suitability of the
information for their particular purposes. In no way shall the company be
liable for any claims, losses, or damages of any third party or for lost
profits or any special, indirect, incidental, consequential or exemplary
damages, howsoever arising, even if the company has been advised of
the possibility of such damages.
--------------------------------------------------------------------------------
--------------------------------------------------------------------------------
|
|
|
| ALL MSDS PAGES IN THIS GROUP
| | NAME | CAS |
|
Methyl Benzilate, 99%
| 76-89-1 |
|
Methyl (r)-(+)-Lactate
| 17392-83-5 |
|
2-Thiophenecarboxylic acid hydrazide, 97%
| 2361-27-5 |
|
Acetonyltriphenylphosphonium chloride, 99%
| 1235-21-8 |
|
3,5-Dinitro-2-Methylbenzyl Alcohol, 97%
| 80866-93-9 |
|
Sodium perchlorate monohydrate
| 7601-89-0 |
|
Sodium periodate
| 7790-28-5 |
|
2,2,5,5-Tetramethyl-4-Methylene-3-Formyl- Imidazolidine-1-Oxyl, Free
| 82814-77-5 |
|
Sucrose Diacetate Hexaisobutyrate (Pract)
| 126-13-6 |
|
Sodium peroxide
| 1310-73-2 |
|
Sodium phosphate dibasic heptahydrate
| 7558-79-4 |
|
Dichloromethane-D2, 100.0 Atom % D
| 1665-00-5 |
|
6-Hydroxydopamine hydrobromide, 99%
| 636-00-0 |
|
Hepta-O-Acetyl-Cellobiosyl-Betha-Azide, 99%
| 33012-50-9 |
|
4-Fluorophenyl isocyanate, 99%
| 1195-45-5 |
|
Potassium Sodium Tartrate Tetrahydrate
| 6381-59-5 |
|
3,4-Dihydroxycinnamic acid, 99+%, predominantly trans isomer
| 331-39-5 |
|
Sodium Pyrophosphate Decahydrate
| 7722-88-5 |
|
Sodium Salicylate
| 54-21-7 |
|
Paraldehyde, 99.5% (gc)
| 123-63-7 |
|
4-Chloro-3-nitrobenzenesulfonyl chloride, 99% (titr.)
| 97-08-5 |
|
8-Hydroxyquinoline-N-oxide, 99%
| 1127-45-3 |
|
3-Bromo-4-Fluorobenzaldehyde, 99%
| 77771-02-9 |
|
1,2:5,6-Di-O-Cyclohexylidene-3-Cyano-Alpha -D-Allofuranose, 93%
| 62293-19-0 |
|
Trans-2-Hexenal, 99%
| 6728-26-3 |
|
Sodium Succinate Hexahydrate
| 6106-21-4 |
|
Sodium sulfate anhydrous
| 7757-82-6 |
|
1-(3-Methoxyphenyl)-piperazine dihydrochloride, 98%
| 6968-76-9 |
|
Sodium Sulfide Nonahydrate
| 1313-82-2 |
|
Glyoxalbis-(2-Hydroxyanil), P.A.
| 1149-16-2 |
|
4'-Methoxyacetophenone, 98%
| 100-06-1 |
|
Sodium Sulfite, Anhydrous
| 7757-83-7 |
|
Quinoline Yellow, Water Soluble
| 8004-92-0 |
|
Sodium L-(+)-tartrate dihydrate
| 868-18-8 |
|
2,5-Dimethylbenzoxazole, 99%
| 5676-58-4 |
|
1-Phenyldodecane, 97%
| 123-01-3 |
|
Sodium Tetraphenyl Boron
| 143-66-8 |
|
Sodium thiocyanate
| 540-72-7 |
|
2,6-Diiodo-4-Nitroaniline, 97%
| 5398-27-6 |
|
Linalool, 97%
| 78-70-6 |
|
Sodium Thiosulfate Anhydrous
| 7772-98-7 |
|
Sodium Thiosulfate Pentahydrate
| 10102-17-7 |
|
Phenoxyacetyl chloride, 98%
| 701-99-5 |
|
2,3:5,6-Di-O-Cyclohexylidene-D-Mannolactone, 98%
| 0-00-1 |
|
Palmitic acid sodium salt, 98%
| 408-35-5 |
|
Diazo Red RC
| 4274-03-7 |
|
Sodium tungstate dihydrate
| 10213-10-2 |
|
Biuret, 99%
| 108-19-0 |
|
5-Chlorobenzotriazole, 99%
| 94-97-3 |
|
Ethyl cyanoformate, 99%
| 623-49-4 |
|
|